Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-13-020171
Filing Date
2013-04-15
Accepted
2013-04-15 15:58:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 91215
  Complete submission text file 0000000000-13-020171.txt   126845
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filed for) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances